These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration. Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H. Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496 [Abstract] [Full Text] [Related]
3. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Pais MJ, Gaspar A, Santana A, Bruges M, Simões J. Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660 [Abstract] [Full Text] [Related]
4. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lui SF, Law CB, Ting SM, Li P, Lai KN. Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075 [Abstract] [Full Text] [Related]
10. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis. Huang TP, Lin CY. Am J Nephrol; 1995 Nov; 15(4):312-7. PubMed ID: 7573189 [Abstract] [Full Text] [Related]
11. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis. Hisano S, Kaku Y, Ueda K, Onoyama K. Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903 [Abstract] [Full Text] [Related]
12. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study. Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D. Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328 [Abstract] [Full Text] [Related]
13. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis. Steinhauer HB, Lubrich-Birkner I, Dreyling KW, Schollmeyer P. Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554 [Abstract] [Full Text] [Related]
14. Subcutaneous recombinant human erythropoietin in patients on CAPD. Lye WC, Lee EJ. Adv Perit Dial; 1991 Feb; 7():285-7. PubMed ID: 1680447 [Abstract] [Full Text] [Related]
15. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients. Theodoridis M, Passadakis P, Kriki P, Panagoutsos S, Yannatos E, Kantartzi K, Sivridis D, Vargemezis V. Perit Dial Int; 2005 Feb; 25(6):564-9. PubMed ID: 16411523 [Abstract] [Full Text] [Related]
19. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD. Icardi A, Paoletti E, Molinelli G. Adv Perit Dial; 1990 Feb; 6():292-5. PubMed ID: 1982830 [Abstract] [Full Text] [Related]
20. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis. Yalçinkaya F, Tümer N, Cakar N, Ozkaya N. Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]